Experiment 69603
Worktypes
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Crocus sativus (IRIDACEAE) |
| Citation | AKHONDZADEH,S: TAHMACEBI-POUR,N: NOORBALA,AA: AMINI,H: FALLAH-POUR,H: JAMSHIDI,AH: KHANI,M:. (2005). CROCUS SATIVUS L. IN THE TREATMENT OF MILD TO MODERATE DEPRESSION: A DOUBLE-BLIND, RAMDOMIZED AND PLACEBO-CONTROLLED TRIAL.. 19() |
| Amount utilized | |
| Compound isolated | |
| Disease | F=18.89, P <0.001). THERE WERE NO SIGNIFICANT DIFFERENCES IN THE TWO GROUPS IN TERMS OF THE OBSERVED SIDE EFFECTS. THE RESULTS OF THIS STUDY INDICATE THE EFFICACY OF CROCUS SATIVUS IN THE TREATMENT OF MILD TO MODERATE DEPRESSION. RECEIVE A CAPSULE OF SAFFRON 30 MG/DAY (BD)(GROUP 1) OR A CAPSULE OF PLACEBO (BD)(GROUP 2) FOR A 6 WK STUDY. AT 6 WKS, CROCUS SATIVUS PRODUCED A SIGNIFICANTLY BETTER OUTCOME ON THE HAMILTON DEPRESSION RATING SCALE THAN THE PLACEBO (D.F.=1, DEPRESSION (DSM IV) PARTICIPATED IN THE TRIAL. PATIENTS HAD A BASELINE HAMILTON RATING SCALE FOR DEPRESSION SCORE OF AT LEAST 18. IN THIS DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-CENTRE AND RANDOMIZED TRIAL, PATIENTS WERE RANDOMLY ASSIGNED TO THE OBJECTIVE OF THIS STUDY WAS TO ASSESS THE EFFICACY OF THE STIGMAS OF CROCUS SATIVUS (SAFFRON) IN THE TREATMENT OF MILD TO MODERATE DEPRESSION IN A 6-WK DOUBLE-BLIND, PLACEBO-CONTROLLED AND RANDOMIZED TRIAL. 40 ADULT OUTPATIENTS WITH MAJOR |
| Dose amount | 30.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Extract | HYDRO-ALCOHOLIC EXT |
| Gender | GIVEN TO BOTH SEXES |